David J Rissmiller

David J Rissmiller

Department Of Psychiatry At The University Of Medicine And Dentistry Of New Jersey-School Of Osteopathic Medicine In Stratford, Cherry Hill, Nj 08002-2051, Usa. Rissmidj@umdnj.edu

Direct Impact

Concepts for which David J Rissmiller has direct influence:

personality disorder
quetiapine borderline
medication investigator
statistically period
abnormal laboratory
exclusion criteria
anxiety inventory

Prominent publications by David J Rissmiller

KOL-Index: 6 Bupropion hydrochloride is currently available in three formulations: immediate-release, sustained-release, and extended-release (ER). Several published reports exist concerning bupropion's history of inducing seizures in both the immediate- and sustained-release formulations. Although the potential of the ER formulation for causing seizures is noted in the drug's prescribing information, ...
Known for
Clonazepam | Release Extended | 8 Months Follow-Up | Bupropions History
KOL-Index: 2 Objective:The objective of this study is to quantitatively examine the efficacy of Seroquel (active ingredient quetiapine fumarate) in subjects with Borderline Personality Disorder (BPD). A secondary objective is to characterize the safety and tolerability of utilizing quetiapine in patients with Borderline Personality Disorder.Design:Investigator initiated, 6-week, non-placebo controlled, ...

Department of Psychiatry at the University of Medicine and Dentistry of New Jersey-School of Osteopathic Medicine in Stratford, Cherry Hill, NJ 08002-2051, USA. rissmidj@umdnj.edu

https://www.g2.com/products/key-opinion-leaders-kols/reviews https://www.bbb.org/us/fl/doral/profile/data-analytics/key-opinion-leaders-0633-92023858 https://www.trustpilot.com/review/keyopinionleaders.com https://www.yelp.com/biz/key-opinion-leaders-miami


© 2022 - Key Opinion Leaders -
Key Opinion Leaders, LLC ,
2025 NW 102 Avenue, Suite 111 Doral , FL   33172